<- Go Home

Nephros, Inc.

Nephros, Inc., a commercial-stage company, develops and sells water solutions to the medical and commercial markets in the United States. The company offers ultrafiltration products that are used in dialysis centers for the removal of biological contaminants from water and bicarbonate concentrate; and in hospitals for the prevention of infection from waterborne pathogens, such as legionella and pseudomonas, as well as in military and outdoor recreation, commercial, and other healthcare facilities. It also manufactures and sells water filters that enhance the taste and odor of water, as well as reduce biofilm, bacteria, cysts, particulates, heavy metals, chemical compounds, scale build-up in downstream equipment, and other various contaminants. It markets its products to food service, hospitality, convenience store, and health care markets, as well as medical institutions. The company was incorporated in 1997 and is headquartered in South Orange, New Jersey.

Market Cap

$46.8M

Volume

26.5K

Cash and Equivalents

$5.2M

EBITDA

$1.6M

Tax Rate Collected

N/A

Tax Rate Ratio

N/A

Gross Profit

$11.3M

Profit Margin

63.24%

52 Week High

$5.98

52 Week Low

$1.39

Dividend

N/A

Price / Book Value

4.67

Price / Earnings

31.69

Price / Tangible Book Value

5.35

Enterprise Value

$42.7M

Enterprise Value / EBITDA

20.76

Operating Income

$1.4M

Return on Equity

16.29%

Return on Assets

7.64

Cash and Short Term Investments

$5.2M

Debt

$1.2M

Equity

$10.0M

Revenue

$17.9M

Unlevered FCF

$2.1M

Sector

Machinery

Category

N/A

Hedge Funds that own this stock

PREMIUM

Upgrade to Yellowbrick Premium to unlock the Professional Funds that own this company (and many other perks).

Upgrade to Yellowbrick Premium

Yellowbrick Portfolios that own this stock

PREMIUM

Upgrade to Yellowbrick Premium to unlock the Yellowbrick portfolios that own this company (and many other perks).

Upgrade to Yellowbrick Premium

Company Stock Pitches